Valganciclovir to Prevent Cytomegalovirus Infection in Patients Following Donor Stem Cell Transplantation
Clinical trial NCT00016068 · COMPLETED
Trial details
- NCT number
- NCT00016068
- Sponsor
- Fred Hutchinson Cancer Center
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2001-01-01
- Enrollment
- 184
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.